{
  "schemaVersion": 2,
  "eyebrow": "Emergency Medicine",
  "title": "Hypertensive Emergency Targets",
  "summary": "Manage hypertensive emergency by identifying the injured organ before selecting a blood pressure target. Most patients require controlled intravenous reduction of mean arterial pressure, while aortic dissection, stroke, pulmonary edema, acute coronary syndromes, and pregnancy require syndrome-specific targets and agents.",
  "seoDescription": "Hypertensive emergency blood pressure targets by clinical syndrome, including aortic dissection, stroke, pulmonary edema, ACS, renal failure, and eclampsia.",
  "clinicalQuestion": "What blood pressure reduction target and timing should be used for each hypertensive emergency syndrome?",
  "specialty": "Emergency Medicine",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "hypertensive emergency",
    "blood pressure targets",
    "hypertensive crisis",
    "intravenous antihypertensives",
    "aortic dissection",
    "intracerebral hemorrhage"
  ],
  "keyTakeaways": [
    "Severe blood pressure elevation becomes a hypertensive emergency only when acute hypertension-mediated organ injury is present; the treatment target is determined by the organ-injury syndrome, not the presenting blood pressure alone. [6][13][17]",
    "For most hypertensive emergencies, reduce mean arterial pressure by no more than 20% to 25% in the first hour, then toward 160/100 to 110 mm Hg over 2 to 6 hours, with further cautious reduction during the next 24 to 48 hours. [2][12][13][16][20]",
    "Acute aortic dissection requires immediate anti-impulse therapy, generally intravenous esmolol within 5 to 10 minutes and systolic blood pressure below 120 mm Hg; add a vasodilator only after beta-blockade if pressure remains elevated. [13][15]",
    "Do not use intravenous drugs or rapid blood pressure reduction for severe asymptomatic hypertension without acute organ injury; initiate or intensify chronic oral therapy and reduce blood pressure over days to weeks. [2][18][19]",
    "In hypertensive acute pulmonary edema, use intravenous nitroglycerin, clevidipine, or nitroprusside; avoid beta-blockers in acute pulmonary edema. [11][20]"
  ],
  "sections": [
    {
      "id": "establish-emergency-and-monitoring",
      "eyebrow": "First Decision",
      "heading": "Confirm acute organ injury before applying emergency targets",
      "intro": "A number alone does not establish an indication for rapid intravenous blood pressure reduction.",
      "paragraphs": [
        "Classify the presentation as hypertensive emergency when severe blood pressure elevation is accompanied by acute hypertension-mediated organ injury, including encephalopathy, intracerebral hemorrhage, acute ischemic stroke, acute myocardial infarction or unstable angina, acute left ventricular failure with pulmonary edema, acute kidney injury, aortic dissection, or eclampsia. A systolic blood pressure of 180 mm Hg or greater and/or diastolic blood pressure of 120 mm Hg or greater is a common threshold for severe elevation, but organ injury—not a fixed pressure threshold—drives emergency treatment. [6][13][16][17][20]",
        "Use a targeted evaluation to identify the branch that changes the pressure goal: neurologic deficit or altered mentation prompts stroke or encephalopathy assessment; chest or back pain raises concern for acute coronary syndrome or aortic dissection; hypoxemia with pulmonary edema identifies acute heart failure; and worsening creatinine or oliguria supports acute renal involvement. Obtain electrocardiography and laboratory testing when clinical findings suggest organ injury, and use directed imaging for suspected neurologic or aortic disease. [17][19]",
        "Admit patients with hypertensive emergency for titratable intravenous therapy and continuous hemodynamic monitoring, generally in an intensive care setting. Avoid precipitous reduction because chronic hypertension shifts autoregulation and excessive early lowering can cause cerebral, coronary, or renal hypoperfusion. [2][13][17]"
      ],
      "bullets": [
        "Treat immediately as an emergency when severe blood pressure elevation accompanies aortic dissection, pulmonary edema, acute coronary ischemia, acute renal failure, stroke or intracranial hemorrhage, encephalopathy, or eclampsia. [13][20]",
        "Do not equate headache alone, anxiety, medication nonadherence, or a single markedly elevated reading with acute organ injury; assess for the specific injury syndrome before choosing intravenous therapy. [2][17][19]",
        "Use frequent reassessment of blood pressure and the affected organ system while titrating treatment; the intended target may change as neurologic, respiratory, ischemic, or perfusion findings evolve. [2][13]"
      ],
      "subsections": [],
      "table": {
        "caption": "Initial distinction between hypertensive emergency and severe asymptomatic hypertension. [2][13][18][19]",
        "columns": [
          "Clinical state",
          "Defining finding",
          "Immediate blood pressure strategy",
          "Disposition"
        ],
        "rows": [
          [
            "Hypertensive emergency",
            "Severe elevation with acute hypertension-mediated organ injury. [13][17]",
            "Use titratable intravenous therapy with syndrome-specific targets. [2][13]",
            "Hospitalize with continuous monitoring, commonly intensive care. [9][13]"
          ],
          [
            "Severe asymptomatic hypertension",
            "Typically systolic blood pressure at least 180 mm Hg or diastolic blood pressure at least 110 mm Hg without acute target-organ injury. [18][19]",
            "Do not rapidly lower blood pressure or use parenteral agents; initiate or adjust oral chronic therapy and reduce over days to weeks. [18]",
            "Usually outpatient management; consider admission for escalating pressure, acute organ injury, or inability to adhere to treatment. [18]"
          ]
        ]
      }
    },
    {
      "id": "default-target-for-most-emergencies",
      "eyebrow": "General Target",
      "heading": "Use staged reduction for most hypertensive emergencies",
      "intro": "Apply this sequence unless the clinical syndrome has a more urgent or different target.",
      "paragraphs": [
        "For most hypertensive emergencies, lower mean arterial pressure by no more than 20% to 25% during the first hour. If the patient is clinically stable, continue gradual reduction toward approximately 160/100 to 110 mm Hg during the next 2 to 6 hours, then cautiously toward 130 to 140 mm Hg over the subsequent 24 to 48 hours. [12][13][16][20]",
        "This staged approach applies to many nonstroke emergencies, including hypertensive encephalopathy and acute renal injury, but should not be used as a substitute for the syndrome-specific targets required in aortic dissection, acute ischemic stroke undergoing reperfusion treatment, intracerebral hemorrhage, acute coronary syndrome, pulmonary edema, or pregnancy-related severe hypertension. [2][11][13][20][22]",
        "Choose a short-acting titratable intravenous agent that fits the injury pattern. Commonly recommended options across emergency syndromes include nicardipine, clevidipine, labetalol, esmolol, sodium nitroprusside, nitroglycerin, hydralazine, and phentolamine; selection should prioritize the clinical syndrome and contraindications rather than a universal first-line drug. [12][22]"
      ],
      "bullets": [
        "Avoid a greater-than-25% first-hour mean arterial pressure reduction in the usual emergency pathway. [13][16]",
        "Reassess for hypotension, new neurologic deficits, worsening ischemia, declining urine output, or altered mental status during titration; these findings require reassessment of the target and infusion rate. [2][13]",
        "Use syndrome-specific targets rather than the default pathway when dissection, stroke, intracranial hemorrhage, acute pulmonary edema, acute coronary syndrome, or eclampsia is present. [11][13][20][22]"
      ],
      "subsections": [],
      "table": {
        "caption": "Default staged blood pressure reduction for hypertensive emergency when no syndrome-specific exception applies. [12][13][16][20]",
        "columns": [
          "Time from treatment",
          "Blood pressure objective",
          "Operational implication"
        ],
        "rows": [
          [
            "First hour",
            "Lower mean arterial pressure by no more than 20% to 25%. [12][13][16][20]",
            "Use a titratable intravenous agent and continuous monitoring. [2][13]"
          ],
          [
            "2 to 6 hours",
            "Reduce toward 160/100 to 110 mm Hg in clinically stable patients. [12][13][16][20]",
            "Continue gradual titration rather than pursuing immediate normotension. [13][16]"
          ],
          [
            "24 to 48 hours",
            "Cautiously reduce toward 130 to 140 mm Hg. [12][13]",
            "Transition planning depends on the precipitating syndrome and long-term antihypertensive regimen. [17][22]"
          ]
        ]
      }
    },
    {
      "id": "aortic-and-cardiopulmonary-targets",
      "eyebrow": "Cardiovascular Emergencies",
      "heading": "Use rapid anti-impulse control for dissection and syndrome-directed targets for pulmonary edema or ACS",
      "intro": "Aortic dissection is the principal exception to gradual first-hour reduction.",
      "paragraphs": [
        "For acute aortic dissection, initiate intravenous esmolol within 5 to 10 minutes to reduce impulse stress and target systolic blood pressure below 120 mm Hg. If systolic pressure remains elevated after beta-blockade, add a vasodilator such as nitroglycerin or nitroprusside; beta-blockade first avoids reflex tachycardia from vasodilator monotherapy. [15]",
        "For hypertensive acute pulmonary edema, select intravenous nitroglycerin, clevidipine, or sodium nitroprusside. Beta-blockers are contraindicated in acute pulmonary edema. Nitroglycerin may be started at 5 mcg/min, with a reported maximum infusion rate of 20 mcg/min; sodium nitroprusside may be started at 0.3 to 0.5 mcg/kg/min, with a reported maximum of 10 mcg/kg/min. [20]",
        "In acute coronary syndrome with hypertension, decrease mean arterial pressure by approximately 20% to 25% over 1 to 2 hours and then more gradually while preparing for emergency intervention. A target systolic pressure below 140 mm Hg is recommended in cited guidance; avoid lowering diastolic pressure below 70 mm Hg because coronary perfusion may be compromised. AHA/ACC guidance cited in the review includes esmolol or labetalol, an ACE inhibitor, and/or nitroglycerin; do not use beta-blockers when moderate to severe pulmonary edema coexists. [11]"
      ],
      "bullets": [
        "Acute dissection: beta-block first, then add a vasodilator only if further pressure reduction is required; pursue systolic blood pressure below 120 mm Hg. [15]",
        "Acute pulmonary edema: use nitroglycerin, clevidipine, or nitroprusside; avoid beta-blockade. [20]",
        "Acute coronary syndrome: avoid excessive diastolic reduction, particularly below 70 mm Hg in cited guidance. [11]"
      ],
      "subsections": [],
      "table": {
        "caption": "Blood pressure targets and intravenous agent selection in cardiovascular hypertensive emergencies. [11][15][20]",
        "columns": [
          "Syndrome",
          "Target and timing",
          "Preferred strategy",
          "Critical exception"
        ],
        "rows": [
          [
            "Acute aortic dissection",
            "Initiate immediate control; maintain systolic blood pressure below 120 mm Hg. [15]",
            "Intravenous esmolol within 5 to 10 minutes; add nitroglycerin or nitroprusside after beta-blockade if needed. [15]",
            "Do not begin vasodilator therapy before controlling heart rate and impulse with beta-blockade. [15]"
          ],
          [
            "Acute pulmonary edema",
            "Use emergency titration; no separate numerical target is specified in the cited source. [20]",
            "Intravenous nitroglycerin, clevidipine, or nitroprusside. [20]",
            "Beta-blockers are contraindicated. [20]"
          ],
          [
            "Acute coronary syndrome",
            "Reduce mean arterial pressure by 20% to 25% over 1 to 2 hours; target systolic pressure below 140 mm Hg. [11]",
            "Esmolol or labetalol, ACE inhibitor, and/or nitroglycerin. [11]",
            "Avoid diastolic pressure below 70 mm Hg; avoid beta-blockers with moderate to severe pulmonary edema. [11]"
          ]
        ]
      }
    },
    {
      "id": "neurologic-and-pregnancy-targets",
      "eyebrow": "Neurologic and Obstetric Exceptions",
      "heading": "Match targets to hemorrhage, ischemic stroke reperfusion eligibility, or pregnancy",
      "intro": "Neurologic emergencies require different targets because overly rapid reduction can worsen cerebral perfusion.",
      "paragraphs": [
        "For intracerebral hemorrhage, AHA/ASA guidance cited in the literature targets systolic blood pressure of 140 mm Hg. In patients presenting with systolic pressure above 220 mm Hg, use greater caution because intensive reduction may cause hypoperfusion in the setting of right-shifted cerebral autoregulation. [2] Other cited guidance recommends reducing systolic pressure to not less than 140 mm Hg within 6 hours when presenting pressure is 150 to 220 mm Hg. [11]",
        "For acute ischemic stroke, do not automatically apply the general hypertensive-emergency target. When thrombolytic therapy is planned, lower blood pressure to below 185/110 mm Hg before treatment; the cited source recommends a goal of approximately 15% reduction during the first 24 hours when blood pressure control is required. [22] Patients undergoing reperfusion therapy may have adverse outcomes when blood pressure is lowered below 140 mm Hg. [12]",
        "Treat acute-onset severe hypertension in pregnancy at systolic blood pressure of at least 160 mm Hg and/or diastolic blood pressure of at least 110 mm Hg as an obstetric emergency. Cited treatment options include labetalol, nicardipine, or hydralazine; eclampsia is an exception to the usual staged reduction approach and requires more immediate control in an intensive care setting. [11][13][22]",
        "For hypertensive encephalopathy without hemorrhage or ischemic stroke-specific considerations, use the default staged reduction pathway with a titratable intravenous agent, rather than immediate normalization. Clevidipine, labetalol, esmolol, nicardipine, fenoldopam, and nitroprusside are listed options. [13][22]"
      ],
      "bullets": [
        "Intracerebral hemorrhage: target systolic blood pressure about 140 mm Hg; avoid excessive lowering below this threshold in cited recommendations. [2][11]",
        "Ischemic stroke considered for thrombolysis: achieve blood pressure below 185/110 mm Hg before treatment. [22]",
        "Pregnancy: systolic blood pressure at least 160 mm Hg or diastolic blood pressure at least 110 mm Hg is acute severe hypertension requiring urgent therapy. [11]"
      ],
      "subsections": [],
      "table": {
        "caption": "Blood pressure targets in neurologic and pregnancy-related hypertensive emergencies. [2][11][12][22]",
        "columns": [
          "Syndrome",
          "Actionable pressure target",
          "Timing or treatment implication",
          "Important limitation"
        ],
        "rows": [
          [
            "Intracerebral hemorrhage",
            "Target systolic blood pressure 140 mm Hg. [2]",
            "For systolic pressure 150 to 220 mm Hg, cited AHA/ACC guidance recommends reduction to not less than 140 mm Hg within 6 hours. [11]",
            "Use caution when presenting systolic pressure exceeds 220 mm Hg because intensive lowering may cause hypoperfusion. [2]"
          ],
          [
            "Ischemic stroke undergoing thrombolysis",
            "Blood pressure below 185/110 mm Hg before thrombolytic therapy. [22]",
            "When control is required, cited guidance uses approximately 15% reduction in the first 24 hours. [22]",
            "Avoid extrapolating hemorrhage targets; lowering below 140 mm Hg during reperfusion therapy is associated with adverse outcomes. [12]"
          ],
          [
            "Acute severe hypertension in pregnancy or eclampsia",
            "Treat at systolic blood pressure at least 160 mm Hg and/or diastolic blood pressure at least 110 mm Hg. [11]",
            "Use urgent intravenous treatment; labetalol, nicardipine, and hydralazine are listed options. [22]",
            "Eclampsia requires more immediate and aggressive control than the standard staged pathway. [13]"
          ]
        ]
      }
    },
    {
      "id": "renal-injury-and-transition",
      "eyebrow": "Renal and Disposition Decisions",
      "heading": "Treat acute renal involvement with controlled intravenous reduction and avoid emergency treatment when injury is absent",
      "intro": "Renal dysfunction changes agent selection and lowers the threshold for targeted evaluation.",
      "paragraphs": [
        "When severe hypertension is accompanied by acute renal failure, cited preferred intravenous options include clevidipine, fenoldopam, and nicardipine. Fenoldopam may be initiated at 0.1 to 0.3 mcg/kg/min and titrated up to 1.6 mcg/kg/min; nicardipine may be initiated at 5 mg/h and titrated up to 30 mg/h. [20] In an emergency-department cohort with renal dysfunction, 92% of patients receiving intravenous nicardipine reached target systolic pressure within 30 minutes versus 78% receiving labetalol. [20]",
        "In patients with chronic kidney disease, heart failure, coronary artery disease, or previous stroke who have severe pressure elevation without clear acute injury, use a lower threshold for creatinine testing, electrocardiography, or imaging when symptoms or examination findings raise concern for evolving organ injury. [19] Do not infer acute kidney injury from chronic creatinine elevation without evidence of an acute change or compatible clinical syndrome.",
        "After stabilization, identify and address the precipitant, including medication nonadherence, renal or endocrine disorders, and sympathomimetic drug exposure when relevant. Patients without acute organ injury should receive initiation or adjustment of oral antihypertensive therapy rather than intravenous treatment; gradual pressure reduction over several days to weeks is recommended. [15][17][18]"
      ],
      "bullets": [
        "Acute renal failure with hypertensive emergency: consider nicardipine, clevidipine, or fenoldopam and use the default staged reduction target unless another syndrome supersedes it. [20]",
        "Severe asymptomatic hypertension: immediate diagnostic testing rarely changes short-term management, and parenteral therapy is not indicated. [18]",
        "Consider hospital admission without documented acute injury when blood pressure is escalating, acute injury emerges, or treatment adherence cannot be assured. [18]"
      ],
      "subsections": [],
      "table": {
        "caption": "Renal and post-stabilization decisions in severe hypertension. [18][19][20]",
        "columns": [
          "Finding",
          "Next action",
          "Blood pressure approach"
        ],
        "rows": [
          [
            "Acute renal failure with hypertensive emergency",
            "Use titratable intravenous clevidipine, fenoldopam, or nicardipine; monitor response and renal trajectory. [20]",
            "Use staged reduction: no more than 20% to 25% in the first hour, then toward 160/100 to 110 mm Hg over 2 to 6 hours unless another emergency syndrome dictates otherwise. [13][20]"
          ],
          [
            "Chronic kidney disease without definite acute injury",
            "Use a lower threshold for targeted laboratory testing, electrocardiography, or imaging if symptoms suggest evolving injury. [19]",
            "Do not use emergency intravenous reduction solely because blood pressure is markedly elevated. [18][19]"
          ],
          [
            "No acute target-organ injury",
            "Initiate or adjust oral therapy and address adherence barriers; arrange follow-up. [6][18]",
            "Reduce gradually over days to weeks; avoid aggressive lowering and parenteral agents. [18]"
          ]
        ]
      }
    }
  ],
  "faq": [],
  "references": [
    {
      "number": 1,
      "title": "[PDF] General Issues Panel – Clinical Evaluation of Anti-Hypertensive ...",
      "detail": "www.fda.gov",
      "url": "https://www.fda.gov/media/171413/download",
      "authors": "www.fda.gov",
      "host": "www.fda.gov"
    },
    {
      "number": 2,
      "title": "Evaluation and management of hypertensive emergency",
      "detail": "www.bmj.com",
      "url": "https://www.bmj.com/content/bmj/386/bmj-2023-077205.full.pdf",
      "authors": "www.bmj.com",
      "host": "www.bmj.com"
    },
    {
      "number": 3,
      "title": "Prevention, Detection, Evaluation, and Management of High Blood ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/M17-3203",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org"
    },
    {
      "number": 4,
      "title": "J-Shaped Relationship between Blood Pressure and Mortality in ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/0003-4819-136-6-200203190-00007",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org"
    },
    {
      "number": 5,
      "title": "Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis) - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S1089251625000228",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 6,
      "title": "ED-Relevant Takeaways from the New AHA/ACC Hypertension... : Emergency Medicine News",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/em-news/fulltext/2026/01000/ed_relevant_takeaways_from_the_new_aha_acc.9.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 7,
      "title": "Blood pressure management in cardiovascular emergencies: an ... : AME Medical Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/amj/fulltext/2024/09000/blood_pressure_management_in_cardiovascular.7.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 8,
      "title": "Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis)",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S1089251625000228",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 9,
      "title": "Hypertensive Crisis - an overview | ScienceDirect Topics",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/hypertensive-crisis",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 10,
      "title": "The Degree of Blood Pressure Evaluation and End Organ Damage With Severe Hypertension: A Case-Control Study - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915353866",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    },
    {
      "number": 11,
      "title": "Management of hypertensive crisis: British and Irish ... - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10539169",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 12,
      "title": "Current guidelines in hypertension management with special focus ...",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12817854",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 13,
      "title": "Hypertensive Crisis - StatPearls - NCBI Bookshelf - NIH",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK507701",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 14,
      "title": "[PDF] Consultation on draft guideline - Stakeholder comments - NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng136/documents/consultation-comments-and-responses-3",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk"
    },
    {
      "number": 15,
      "title": "Management Strategies for Hypertensive Crisis: A Systematic Review",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11389756",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 16,
      "title": "Acute Hypertension: A Systematic Review and Appraisal of Guidelines - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4295743",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 17,
      "title": "Hypertensive Crisis - StatPearls - NCBI Bookshelf",
      "detail": "ncbi.nlm.nih.gov",
      "url": "https://ncbi.nlm.nih.gov/books/NBK507701?report=printable",
      "authors": "ncbi.nlm.nih.gov",
      "host": "ncbi.nlm.nih.gov"
    },
    {
      "number": 18,
      "title": "Severe Asymptomatic Hypertension: Evaluation and Treatment. - Abstract",
      "detail": "pubmed.ncbi.nlm.nih.gov",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28409616",
      "authors": "pubmed.ncbi.nlm.nih.gov",
      "host": "pubmed.ncbi.nlm.nih.gov"
    },
    {
      "number": 19,
      "title": "Hypertensive Urgency - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/sites/books/NBK513351",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 20,
      "title": "Treatment of hypertensive emergencies",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440310",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 21,
      "title": "Hypertensive Crises",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(15)37535-8/abstract",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org"
    },
    {
      "number": 22,
      "title": "[PDF] A Diagnostic and Clinical Approach to the Practical Management of ...",
      "detail": "applications.emro.who.int",
      "url": "https://applications.emro.who.int/imemrf/224/J-Med-Res-2020-6-4-120-124-eng.pdf",
      "authors": "applications.emro.who.int",
      "host": "applications.emro.who.int"
    },
    {
      "number": 23,
      "title": "Effect of early treatment with anti‐hypertensive drugs on short and ...",
      "detail": "www.cochranelibrary.com",
      "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006743.pub2/references",
      "authors": "www.cochranelibrary.com",
      "host": "www.cochranelibrary.com"
    },
    {
      "number": 24,
      "title": "Hypertensive emergencies: Diagnosis and management",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0033062002700261",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "[PDF] General Issues Panel – Clinical Evaluation of Anti-Hypertensive ...",
      "detail": "www.fda.gov",
      "url": "https://www.fda.gov/media/171413/download",
      "authors": "www.fda.gov",
      "host": "www.fda.gov",
      "snippet": "of treating the broader primary care population to the lower blood pressure target; there is a lack of evidence from randomized clinical trials (RCTs) to support targeting DBP < 80 mmHg; and that the lower SBP targets should coincide with clinical practice which allows for physician discretion to co",
      "score": 0.57952
    },
    {
      "number": 2,
      "title": "Evaluation and management of hypertensive emergency",
      "detail": "www.bmj.com",
      "url": "https://www.bmj.com/content/bmj/386/bmj-2023-077205.full.pdf",
      "authors": "www.bmj.com",
      "host": "www.bmj.com",
      "snippet": "Society is its focus on hypertensive emergency, whereas the other guidelines are broadly on hypertension management. In addition, the AHA, ASA, and ACC have published guidelines specific to stroke and vascular emergencies.78 81 83 While minor differences in drug selection and treatment targets exist",
      "score": 0.70847535
    },
    {
      "number": 3,
      "title": "Prevention, Detection, Evaluation, and Management of High Blood ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/M17-3203",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org",
      "snippet": "After initiation of antihypertensive drug therapy, regardless of ASCVD risk, the recommended BP target is less than 130/80 mm Hg.",
      "score": 0.2605639
    },
    {
      "number": 4,
      "title": "J-Shaped Relationship between Blood Pressure and Mortality in ...",
      "detail": "www.acpjournals.org",
      "url": "https://www.acpjournals.org/doi/10.7326/0003-4819-136-6-200203190-00007",
      "authors": "www.acpjournals.org",
      "host": "www.acpjournals.org",
      "snippet": "Lowering blood pressure in hypertensive patients decreases the risk for cardiovascular events. However, clinical trials show a discrepancy",
      "score": 0.15323243
    },
    {
      "number": 5,
      "title": "Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis) - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S1089251625000228",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Title: Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis) - ScienceDirect\n# Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis). Acute severe hypertension encompasses a spectrum of severe blood pressure elevations that can progress to end organ dama",
      "score": 0.74273956
    },
    {
      "number": 6,
      "title": "ED-Relevant Takeaways from the New AHA/ACC Hypertension... : Emergency Medicine News",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/em-news/fulltext/2026/01000/ed_relevant_takeaways_from_the_new_aha_acc.9.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Title: ED-Relevant Takeaways from the New AHA/ACC Hypertension... : Emergency Medicine News\nCondition-specific recommendations and blood pressure cutoffs provided by the AHA/ACC Hypertension Guideline.Abbreviations: AOI, acute organ injury; HBPM, home blood pressure monitoring. The latest American H",
      "score": 0.7309246
    },
    {
      "number": 7,
      "title": "Blood pressure management in cardiovascular emergencies: an ... : AME Medical Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/amj/fulltext/2024/09000/blood_pressure_management_in_cardiovascular.7.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "# Blood pressure management in cardiovascular emergencies: an evidence-based approach : AME Medical Journal. Despite this, there is a paucity of evidence around blood pressure management specifically in acute aortic dissection, hypertensive cardiogenic pulmonary edema, abdominal aortic aneurysm, and",
      "score": 0.67988104
    },
    {
      "number": 8,
      "title": "Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis)",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/abs/pii/S1089251625000228",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "### Am J Emerg Med (2012) \n\n   E.R. Gonzalez _et al._\n### Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension\n\n### Ann Emerg Med (1991) \n   P.K. Whelton _et al._\n### 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guidelin",
      "score": 0.5412882
    },
    {
      "number": 9,
      "title": "Hypertensive Crisis - an overview | ScienceDirect Topics",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/hypertensive-crisis",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "International guidelines have suggested to avoid the term “hypertensive crisis” for the description of an acute and severe increase in blood pressure (BP) and to consider the definition of ‘hypertensive emergencies’ or ‘hypertensive urgencies’ [1][5][6]. These two clinical presentations are characteri",
      "score": 0.52115494
    },
    {
      "number": 10,
      "title": "The Degree of Blood Pressure Evaluation and End Organ Damage With Severe Hypertension: A Case-Control Study - ScienceDirect",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0002962915353866",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "Title: The Degree of Blood Pressure Evaluation and End Organ Damage With Severe Hypertension: A Case-Control Study - ScienceDirect\n## The American Journal of the Medical Sciences. Volume 306, Issue 6, December 1993, Pages 367-370. The American Journal of the Medical Sciences. # Original Manuscripts ",
      "score": 0.55623144
    },
    {
      "number": 11,
      "title": "Management of hypertensive crisis: British and Irish ... - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10539169",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "There is conflicting evidence relating to the impact of admission BP on patient outcomes. Similarly, the benefits of a particular BP target in the immediate period following ACS are uncertain. ESC guidelines recommend reducing SBP in patients with acute coronary events associated with HTN to <140 mm",
      "score": 0.7487387
    },
    {
      "number": 12,
      "title": "Current guidelines in hypertension management with special focus ...",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12817854",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Emergent situations such as hemorrhagic stroke, acute intracerebral hemorrhage (ICH), require more aggressive and tailored management without bringing down the BP too quickly. The ACC/AHA 2025 guideline emphasized BP management in these situations. The guideline suggests lowering the BP to 130–140 m",
      "score": 0.63777614
    },
    {
      "number": 13,
      "title": "Hypertensive Crisis - StatPearls - NCBI Bookshelf - NIH",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK507701",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "Current guidelines recommend that, in most hypertensive emergencies, blood pressure should be lowered by no more than 25% within the 1st hour, followed by a gradual reduction to below 160/120 mm Hg over the subsequent 2 to 6 hours in stable patients. Further reduction to 130 to 140 mm Hg is advised ",
      "score": 0.6238588
    },
    {
      "number": 14,
      "title": "[PDF] Consultation on draft guideline - Stakeholder comments - NICE",
      "detail": "www.nice.org.uk",
      "url": "https://www.nice.org.uk/guidance/ng136/documents/consultation-comments-and-responses-3",
      "authors": "www.nice.org.uk",
      "host": "www.nice.org.uk",
      "snippet": "they are for long-term preventive management of aneurysms. ESC states “In chronic conditions, blood pressure should be controlled below 140/90 mm Hg ... An ideal treatment would be the one that reverses the formation of an aneurysm.” ACCF/AHA state in section “14. Recommendation for Medical Treatmen",
      "score": 0.55420566
    },
    {
      "number": 15,
      "title": "Management Strategies for Hypertensive Crisis: A Systematic Review",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11389756",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "blood pressure control targets are used, or blood pressure targets are crudely extrapolated from guidelines intended primarily for outpatient management. Patients with acute aortic dissection need to be administered intravenous esmolol within 5 to 10 minutes in order to lower their blood pressure ri",
      "score": 0.5501488
    },
    {
      "number": 16,
      "title": "Acute Hypertension: A Systematic Review and Appraisal of Guidelines - PMC",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4295743",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "Three guidelines were identified, sponsored by the American College of Emergency Physicians (ACEP), the National Heart, Lung, and Blood Institute (NHLBI), and the European Society of Hypertension (ESH) in conjunction with the European Society of Cardiology (ESC). AGREE II yielded mean domain (%) and",
      "score": 0.5443418
    },
    {
      "number": 17,
      "title": "Hypertensive Crisis - StatPearls - NCBI Bookshelf",
      "detail": "ncbi.nlm.nih.gov",
      "url": "https://ncbi.nlm.nih.gov/books/NBK507701?report=printable",
      "authors": "ncbi.nlm.nih.gov",
      "host": "ncbi.nlm.nih.gov",
      "snippet": "Title: Hypertensive Crisis - StatPearls - NCBI Bookshelf\n# Hypertensive Crisis. Hypertensive crisis is a severe elevation in blood pressure that may result from uncontrolled hypertension, renal or endocrine disorders, medication nonadherence, or other underlying conditions. Rapid increases in blood ",
      "score": 0.6609831
    },
    {
      "number": 18,
      "title": "Severe Asymptomatic Hypertension: Evaluation and Treatment. - Abstract",
      "detail": "pubmed.ncbi.nlm.nih.gov",
      "url": "https://pubmed.ncbi.nlm.nih.gov/28409616",
      "authors": "pubmed.ncbi.nlm.nih.gov",
      "host": "pubmed.ncbi.nlm.nih.gov",
      "snippet": "Hypertension affects one-third of Americans and is a significant modifiable risk factor for cardiovascular disease, stroke, renal disease, and death. Severe asymptomatic hypertension is defined as severely elevated blood pressure (180 mm Hg or more systolic, or 110 mm Hg or more diastolic) without s",
      "score": 0.629889
    },
    {
      "number": 19,
      "title": "Hypertensive Urgency - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/sites/books/NBK513351",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "Hypertensive urgency is a marked elevation in blood pressure without evidence of acute target organ injury, such as pulmonary edema, cardiac ischemia, neurologic deficits, or acute kidney injury. Specific thresholds have been proposed, including a systolic blood pressure greater than 180 mm Hg or di",
      "score": 0.62852204
    },
    {
      "number": 20,
      "title": "Treatment of hypertensive emergencies",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440310",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "The drugs of choice in treating a hypertensive emergency with acute pulmonary edema are intravenous nitroglycerin, clevidipine, or nitroprusside (1,2,5). Beta blockers are contraindicated in the treatment of acute pulmonary edema. Except for acute aortic dissection, the blood pressure in patients wi",
      "score": 0.7311551
    },
    {
      "number": 21,
      "title": "Hypertensive Crises",
      "detail": "journal.chestnet.org",
      "url": "https://journal.chestnet.org/article/S0012-3692(15)37535-8/abstract",
      "authors": "journal.chestnet.org",
      "host": "journal.chestnet.org",
      "snippet": "One to two percent of patients with hypertension have acute elevations of BP that require urgent medical treatment. A hypertensive emergency is associated with acute end-organ damage and requires immediate treatment with a titratable short-acting IV antihypertensive agent. **Risk factors for hyperte",
      "score": 0.7208996
    },
    {
      "number": 22,
      "title": "[PDF] A Diagnostic and Clinical Approach to the Practical Management of ...",
      "detail": "applications.emro.who.int",
      "url": "https://applications.emro.who.int/imemrf/224/J-Med-Res-2020-6-4-120-124-eng.pdf",
      "authors": "applications.emro.who.int",
      "host": "applications.emro.who.int",
      "snippet": "clevidipine Acute pulmonary edema nitroglycerin preferred, fenoldopam, nicardipine, clevidipine Hypertensive encephalopathy clevidipine, labetalol, esmolol, nicardipine, fenoldopam, nitroprusside Acute ischemic stroke or intracranial hemorrhage (when BP control is necessary) Nicardipine, labetalol, ",
      "score": 0.6211049
    },
    {
      "number": 23,
      "title": "Effect of early treatment with anti‐hypertensive drugs on short and ...",
      "detail": "www.cochranelibrary.com",
      "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006743.pub2/references",
      "authors": "www.cochranelibrary.com",
      "host": "www.cochranelibrary.com",
      "snippet": "Efficiency of treatment with nimodipine (calcium antagonist) in patients with acute ischemic stroke: a placebo‐controlled, double‐blind, randomized, multicenter",
      "score": 0.22296266
    },
    {
      "number": 24,
      "title": "Hypertensive emergencies: Diagnosis and management",
      "detail": "www.sciencedirect.com",
      "url": "https://www.sciencedirect.com/science/article/pii/S0033062002700261",
      "authors": "www.sciencedirect.com",
      "host": "www.sciencedirect.com",
      "snippet": "The cerebral edema that occurs as a result of hyperfiltration during pregnancy, which may be detected on CT or MRI scans as ## Hypertension with stroke There is a direct and linear relationship between the chronic level of BP and risk of stroke.18 Furthermore, acute stroke, especially if it involves",
      "score": 0.64020914
    }
  ],
  "publishedAt": "2026-09-15T17:44:21.964646+00:00",
  "updatedAt": "2026-09-15T17:44:21.964646+00:00",
  "readingMinutes": 7,
  "slug": "hypertensive-emergency-targets"
}